U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07727356) titled 'EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders' on July 13.
Brief Summary: The goal of this trial is to learn whether wearable devices and hormone sampling can measure how the body changes during daily-life challenges in adults with endocrine or metabolic disorders. These disorders include conditions such as high blood pressure, adrenal disorders, diabetes, obesity, thyroid disorders, pituitary disorders, and other hormone-related conditions.
The main questions it aims to answer are:
Can wearable devices measure changes in blood pressure, heart rate, sleep, activity, temperature, ...